Clinical Study to Investigate the Safety and Pharmacokinetics of SK3530 Tablet in Renal Impaired Male Patients
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is designed to investigate the effect of renal impairment on the safety and
pharmacokinetics of SK3530 in subjects with renal impairment compared to healthy subjects.